Biodexa Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Employee Share Scheme | 5 | 0.000114% |
Individual Insiders | 240 | 0.00547% |
Hedge Funds | 222,763 | 5.08% |
VC/PE Firms | 273,492 | 6.24% |
Institutions | 338,623 | 7.72% |
Public Companies | 354,433 | 8.08% |
Private Companies | 552,476 | 12.6% |
General Public | 2,642,964 | 60.3% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 1753.5%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
354,428 | US$256.9k | 0% | no data | |||
354,428 | US$256.9k | 0% | no data | |||
273,492 | US$198.2k | 0% | 51.1% | |||
222,763 | US$161.5k | 0% | 1.89% | |||
213,081 | US$154.4k | 0% | 1.67% | |||
157,710 | US$114.3k | 0% | no data | |||
44,593 | US$32.3k | 0% | no data | |||
38,970 | US$28.2k | 0% | no data | |||
24,951 | US$18.1k | 7.21% | no data | |||
12,055 | US$8.7k | 0% | no data | |||
11,700 | US$8.5k | 0% | no data | |||
11,101 | US$8.0k | 972% | no data | |||
6,551 | US$4.7k | 0% | 0.2% | |||
5,236 | US$3.8k | 0% | no data | |||
2,768 | US$2.0k | 0% | 0.24% | |||
1,470 | US$1.1k | 0% | no data | |||
1,354 | US$981.4 | 0% | no data | |||
649 | US$470.4 | 0% | no data | |||
649 | US$470.4 | 0% | no data | |||
612 | US$443.7 | 637% | no data | |||
498 | US$361.0 | 123% | no data | |||
429 | US$310.8 | 0% | no data | |||
373 | US$270.5 | 0% | no data | |||
364 | US$263.8 | 0% | 0.05% | |||
314 | US$227.6 | 0% | no data |